Transforming Early Ovarian Cancer Detection with Advanced Biosensor Technology

🎤 Professor Michael Thompson

🏛 University of Toronto, Canada

🎙 Keynote Presentation

Presentation Title

Multiplexed Sensor-Based Detection of Biomarkers for Early-Stage Ovarian Cancer

Event

2nd Edition of International Cancer and Precision Oncology Conference (ICPOC 2026)

🔬 Advancing Precision Diagnostics Through Biosensor Innovation

Early diagnosis is one of the most important factors in improving survival rates for ovarian cancer patients. At ICPOC 2026, Professor Michael Thompson will present innovative research on multiplexed biosensor technologies designed to detect ovarian cancer biomarkers with greater sensitivity and precision.

His work combines cutting-edge biosensing approaches to simultaneously analyze multiple biomarkers, providing new opportunities for earlier diagnosis and more personalized clinical decision-making.

---

🔍 Key Highlights

✔ Multiplexed biosensor platforms for ovarian cancer

✔ Detection of CA125 and Lysophosphatidic Acid (LPA) biomarkers

✔ Ultra-high frequency acoustic wave sensing

✔ Iron oxide nanoparticle chemiluminescence technology

✔ Electrochemical biosensors using voltammetry

✔ High sensitivity for early-stage cancer detection

✔ Precision medicine applications

✔ Next-generation diagnostic technologies

This research demonstrates how biosensor innovation can improve early cancer diagnosis and contribute to more effective patient management.

---

👨‍🔬 About the Speaker

Professor Michael Thompson is Professor of Bioanalytical Chemistry at the University of Toronto, Canada, and is internationally recognized for pioneering research in biosensor technology.

Career Highlights

🏆 Professor of Bioanalytical Chemistry, University of Toronto

🏆 Pioneer in biosensor research and analytical chemistry

🏆 Robert Boyle Gold Medal – Royal Society of Chemistry

🏆 Elsevier Prize in Biosensor and Bioelectronics Technology

🏆 E.W.R. Steacie Award – Chemical Society of Canada

🏆 2023 Royal Society of Chemistry Horizons Prize in Analytical Science

🏆 International leader in protein surface chemistry, biosensors, and biomedical diagnostics

His research continues to drive advances in precision diagnostics and next-generation healthcare technologies.

---

🌍 Join ICPOC 2026

Meet global leaders in oncology, biosensors, precision medicine, and biomedical innovation.

📅 November 23–25, 2026

📍 Singapore & Online

🌐 Official Website
https://cancer.miconferences.com/

📄 Submit Abstract

https://cancer.miconferences.com/abstract-submission

#ICPOC2026 #OvarianCancer #Biosensors #CancerDiagnostics #PrecisionMedicine #CancerResearch #MedicalInnovation #BioanalyticalChemistry #OncologyConference

Advancing Deep Tumor Detection Through Confocal X-ray Fluorescence Imaging

🎤 Professor Rodolfo Gabriel Figueroa Saavedra

🏛 Universidad de La Frontera, Chile

🎙 Keynote Presentation

Presentation Title

Precise Deep Detection of Tumoral Biomarkers Using Large-Scale Confocal X-ray Fluorescence

Event

2nd Edition of International Cancer and Precision Oncology Conference (ICPOC 2026)

---

🔬 Revolutionizing Cancer Imaging with Advanced X-ray Fluorescence Technology

Early and accurate tumor detection remains one of the greatest challenges in modern oncology. At ICPOC 2026, Professor Rodolfo Gabriel Figueroa Saavedra will present pioneering research on large-scale confocal X-ray fluorescence (XRF) technology for the precise detection of deep-seated tumor biomarkers.

His work introduces an innovative imaging platform designed to improve molecular imaging and support future image-guided cancer therapies through advanced theranostic technologies.

🔍 Key Highlights

✔ Large-scale Confocal X-ray Fluorescence (XRF)

✔ Deep detection of tumor biomarkers up to 15 cm

✔ Gadolinium-based biomarker imaging

✔ Low-dose imaging with rapid acquisition

✔ Improved signal-to-background ratio

✔ Real-time molecular imaging

✔ COXIRIS theranostic platform

✔ Patented and patent-pending technologies

The presented research demonstrates the potential of confocal XRF systems to enhance cancer diagnosis and pave the way for next-generation image-guided precision oncology.

---

👨‍🔬 About the Speaker

Professor Rodolfo Gabriel Figueroa Saavedra is a distinguished Radiation Physicist and Full Professor at Universidad de La Frontera, Chile.

Career Highlights

🏆 Director, Centro de Excelencia de Física e Ingeniería en Salud

🏆 Founder of Chile's first Master's Program in Medical Physics

🏆 Inventor of CONVERAY and COXIRIS technologies

🏆 Approximately 24 patents

🏆 Around 100 scientific publications

🏆 Internationally recognized expert in medical physics, radiation sciences, theranostics, and biomedical engineering

His groundbreaking research is driving innovation in cancer detection, radiotherapy, and molecular imaging technologies.

---

🌍 Join ICPOC 2026

Discover the latest advances in precision oncology, cancer imaging, and translational research at ICPOC 2026.

📅 November 23–25, 2026

📍 Singapore & Online

🌐 Official Website
https://cancer.miconferences.com/

📝 Register
https://cancer.miconferences.com/register

📄 Submit Abstract
https://cancer.miconferences.com/abstract-submission

#ICPOC2026 #MedicalPhysics #CancerImaging #Theranostics #XRF #MolecularImaging #PrecisionOncology #CancerResearch #BiomedicalEngineering

Unlocking the Hidden Power of Noncoding RNA in Cancer Research

🎤 Founder & CEO Anyou Wang

🏛 DIFIBER LLC, United States

🎙 Keynote Presentation

Presentation Title

Deep systems insights into the conceptual breakthrough of the noncoding RNA functional network and its role in cancer

Event

2nd Edition of International Cancer and Precision Oncology Conference (ICPOC 2026)

---

🔬 Redefining Cancer Biology Through Artificial Intelligence

Advances in computational biology, big data, and artificial intelligence are transforming our understanding of cancer. At ICPOC 2026, Dr. Anyou Wang will present groundbreaking research that challenges the traditional protein-centric view of biology by revealing the critical role of noncoding RNAs (ncRNAs) in cancer development and progression.

His research demonstrates how ncRNAs function as powerful endogenous regulators and highlights their universal significance across multiple cancer types.

---

🔍 Key Highlights

✔ Discovery of the functional network of noncoding RNAs (ncRNAs)

✔ AI-powered analysis of large-scale biological datasets

✔ Computational biology approaches for cancer research

✔ Systems-level understanding of cancer biology

✔ ncRNAs as key regulators in tumor development

✔ Cancer genomics and precision oncology

✔ Evolutionary insights into disease mechanisms

✔ Future applications of AI in personalized cancer care

This keynote offers a new perspective on cancer biology and illustrates how artificial intelligence is accelerating discoveries that may shape the future of precision medicine.

---

👨‍🔬 About the Speaker

Dr. Anyou Wang is the Founder and CEO of DIFIBER LLC, United States, and a leading scientist in computational biology, artificial intelligence, and big data analytics.

Career Highlights

🏆 Founder & CEO, DIFIBER LLC

🏆 Graduate of the University of California, Riverside

🏆 Pioneer in computational biology and AI-driven biomedical research

🏆 Discovered the unique functional system of noncoding RNAs

🏆 Demonstrated the central role of ncRNAs across multiple cancers

🏆 Developed computational algorithms to study SARS-CoV-2 evolution

🏆 Research interests include AI, genomics, precision medicine, and systems biology

His innovative work is reshaping the understanding of molecular biology and opening new avenues for cancer diagnosis and treatment.

---

🌍 Join ICPOC 2026

Be part of a global forum where experts explore the latest advances in cancer research, genomics, artificial intelligence, and precision oncology.

📅 November 23–25, 2026

📍 Singapore & Online

🌐 Official Website
https://cancer.miconferences.com/

📝 Register
https://cancer.miconferences.com/register

📄 Submit Abstract
https://cancer.miconferences.com/abstract-submission

#ICPOC2026 #CancerResearch #ArtificialIntelligence #ComputationalBiology #NoncodingRNA #CancerGenomics #PrecisionMedicine #CancerInnovation #OncologyConference

Fluorine-Doped Graphene: A Promising Advance in Photodynamic Cancer Therapy

🎤 Professor Paulo Cesar De Morais

🏛 Catholic University of Brasilia, Brazil

🎙 Keynote Presentation

Presentation Title

Prospecting fluorine-doped graphene in photodynamic therapy

Event

2nd Edition of International Cancer and Precision Oncology Conference (ICPOC 2026)

---

🔬 Exploring Next-Generation Nanomaterials for Cancer Therapy

Photodynamic therapy (PDT) has emerged as a promising minimally invasive approach for treating cancer. During ICPOC 2026, Professor Paulo Cesar De Morais will present innovative research on fluorine-doped graphene quantum dots (F@GQDs) and their potential to enhance the effectiveness of photodynamic therapy.

This presentation focuses on overcoming key challenges associated with conventional graphene quantum dots, including limited singlet oxygen quantum yield, poor water solubility, and biocompatibility.

🔍 Key Highlights

✔ Development of fluorine-doped graphene quantum dots (F@GQDs)

✔ Average particle size below 3 nm

✔ Approximately 2% fluorine doping

✔ Enhanced water solubility

✔ Improved biocompatibility

✔ Strong green fluorescence

✔ Quantum yield exceeding 13%

✔ Successful in vitro photodynamic activity

These findings demonstrate the potential of advanced nanomaterials to improve targeted cancer therapies and support the future development of safer, more effective treatment strategies.

---

👨‍🔬 About the Speaker

Professor Paulo Cesar De Morais is an internationally recognized physicist and nanotechnology researcher.

Career Highlights

🏆 Emeritus Professor, University of Brasilia

🏆 Professor, Catholic University of Brasilia

🏆 CNPq-1A Research Fellow

🏆 H-index: 59

🏆 13,500+ citations

🏆 500+ scientific publications

🏆 200+ invited international lectures across 35 countries

🏆 16 patents

🏆 Postdoctoral Research at Bell Communications Research, USA

His research has significantly contributed to nanotechnology, solid-state physics, and biomedical applications of advanced materials.

---

🌍 Join ICPOC 2026

Meet internationally renowned experts and discover the latest advances in cancer research and precision oncology.

📅 November 23–25, 2026

📍 Singapore & Online

🌐 Official Website
https://cancer.miconferences.com/

📝 Register
https://cancer.miconferences.com/register

📄 Submit Abstract
https://cancer.miconferences.com/abstract-submission

#ICPOC2026 #PhotodynamicTherapy #Nanotechnology #GrapheneQuantumDots #CancerResearch #PrecisionOncology #CancerInnovation #BiomedicalEngineering #CancerScience

Personalized & Precision Medicine: Transforming the Future of Cancer Care

🎤 Vice-Director Sergey Suchkov

🏛 N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation

🎙 Keynote Presentation

Presentation Title

Personalized and Precision Medicine (PPM) through the view of biodesign-inspired translational research: An option for clinical oncologists, caregivers and consumers to secure human biosafety

Event

2ndEdition of International Cancer and Precision Oncology Conference (ICPOC 2026)

---

🔬 Advancing Precision Oncology Through Genomics

Modern oncology is rapidly evolving from generalized treatment approaches toward Personalized and Precision Medicine (PPM). In this keynote presentation, Dr. Sergey Suchkov will discuss how genomics, molecular diagnostics, and translational research are revolutionizing cancer prevention, diagnosis, and treatment.

His presentation highlights the growing importance of identifying predictive biomarkers before clinical disease develops, enabling earlier intervention and more effective patient-specific therapies.

🔍 Key Highlights

✔ Personalized & Precision Oncology (PPO)

✔ Genomic Profiling & Biomarker Discovery

✔ Next-Generation Sequencing (NGS)

✔ Genome-Wide Association Studies (GWAS)

✔ Targeted Cancer Therapies

✔ Predictive, Preventive & Personalized Medicine

✔ Translational Research & Biodesign

✔ Artificial Intelligence & Healthcare Data Integration

✔ Future Clinical Guidelines for Precision Medicine

These innovations are expected to transform oncology by enabling clinicians to tailor treatments based on each patient's unique molecular profile, improving clinical outcomes while minimizing unnecessary therapies.

---

👨‍🔬 About the Speaker

Vice-Director Sergey Suchkov is an internationally recognized physician, scientist, and expert in personalized medicine.

Career Highlights

🏆 MD, PhD, Doctor of Medical Sciences

🏆 Vice-Director, National Center for Human Photosynthesis, Mexico

🏆 Member of the New York Academy of Sciences

🏆 Member of the American Chemical Society (ACS)

🏆 Member of the American Heart Association (AHA)

🏆 Member of the European Association for Predictive, Preventive and Personalized Medicine (EPMA)

🏆 Member of ARVO, ISER, PMC, and numerous international scientific organizations

His distinguished career spans clinical immunology, genomics, predictive medicine, ophthalmology, translational research, and precision oncology.

---

🌍 Join ICPOC 2026

Meet global experts shaping the future of cancer research and precision medicine.

📅 November 23–25, 2026

📍 Singapore & Online

🌐 Official Website:
https://cancer.miconferences.com/

📝 Register:
https://cancer.miconferences.com/register

📄 Submit Abstract:
https://cancer.miconferences.com/abstract-submission

#ICPOC2026 #PrecisionOncology #PersonalizedMedicine #CancerResearch #Genomics #TranslationalResearch #Biomarkers #CancerScience #ClinicalOncology #CancerInnovation